WO2022147873A1 - Avocado oil-in-water liquid fermented product, and preparation method therefor and use thereof - Google Patents
Avocado oil-in-water liquid fermented product, and preparation method therefor and use thereof Download PDFInfo
- Publication number
- WO2022147873A1 WO2022147873A1 PCT/CN2021/075386 CN2021075386W WO2022147873A1 WO 2022147873 A1 WO2022147873 A1 WO 2022147873A1 CN 2021075386 W CN2021075386 W CN 2021075386W WO 2022147873 A1 WO2022147873 A1 WO 2022147873A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- avocado
- water liquid
- oil
- fermentation
- fermented product
- Prior art date
Links
- 235000008673 Persea americana Nutrition 0.000 title claims abstract description 122
- 239000007788 liquid Substances 0.000 title claims abstract description 100
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 95
- 238000002360 preparation method Methods 0.000 title claims description 29
- 238000004519 manufacturing process Methods 0.000 title description 4
- 240000002426 Persea americana var. drymifolia Species 0.000 title 1
- 244000025272 Persea americana Species 0.000 claims abstract description 121
- 238000000855 fermentation Methods 0.000 claims abstract description 117
- 230000004151 fermentation Effects 0.000 claims abstract description 116
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000002537 cosmetic Substances 0.000 claims abstract description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 31
- 241000186684 Lactobacillus pentosus Species 0.000 claims description 28
- 230000001580 bacterial effect Effects 0.000 claims description 23
- 238000004321 preservation Methods 0.000 claims description 19
- 244000005700 microbiome Species 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 13
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 230000003020 moisturizing effect Effects 0.000 claims description 11
- 241000235004 Saccharomycopsis fibuligera Species 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 9
- 235000020662 avocado pulp Nutrition 0.000 claims description 7
- 239000002054 inoculum Substances 0.000 claims description 7
- 230000000813 microbial effect Effects 0.000 claims description 7
- 239000002068 microbial inoculum Substances 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 241000235070 Saccharomyces Species 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 235000021302 avocado oil Nutrition 0.000 abstract description 21
- 239000008163 avocado oil Substances 0.000 abstract description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 15
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 230000001965 increasing effect Effects 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 239000004094 surface-active agent Substances 0.000 abstract description 9
- 230000006378 damage Effects 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 7
- 230000003859 lipid peroxidation Effects 0.000 abstract description 7
- 238000001035 drying Methods 0.000 abstract description 6
- 238000005502 peroxidation Methods 0.000 abstract description 6
- 230000008439 repair process Effects 0.000 abstract description 6
- 150000004676 glycans Chemical class 0.000 abstract description 4
- 102000039446 nucleic acids Human genes 0.000 abstract description 4
- 108020004707 nucleic acids Proteins 0.000 abstract description 4
- 150000007523 nucleic acids Chemical class 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000005017 polysaccharide Substances 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 150000003384 small molecules Chemical class 0.000 abstract description 3
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 231100000344 non-irritating Toxicity 0.000 abstract description 2
- 239000006041 probiotic Substances 0.000 abstract description 2
- 235000018291 probiotics Nutrition 0.000 abstract description 2
- 230000002949 hemolytic effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 75
- 239000000523 sample Substances 0.000 description 59
- 239000000243 solution Substances 0.000 description 37
- 230000000052 comparative effect Effects 0.000 description 33
- 108090000765 processed proteins & peptides Proteins 0.000 description 30
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 28
- 238000012360 testing method Methods 0.000 description 26
- 239000003921 oil Substances 0.000 description 22
- 235000019198 oils Nutrition 0.000 description 22
- 102000004196 processed proteins & peptides Human genes 0.000 description 21
- 238000002835 absorbance Methods 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 19
- 239000002609 medium Substances 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 19
- 238000012216 screening Methods 0.000 description 16
- 108091005804 Peptidases Proteins 0.000 description 15
- 239000004365 Protease Substances 0.000 description 15
- 235000019197 fats Nutrition 0.000 description 15
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- 229920001184 polypeptide Polymers 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- 239000000284 extract Substances 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 239000003876 biosurfactant Substances 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 7
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 7
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 206010018910 Haemolysis Diseases 0.000 description 7
- 239000005642 Oleic acid Substances 0.000 description 7
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 7
- 239000000306 component Substances 0.000 description 7
- 230000008588 hemolysis Effects 0.000 description 7
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 7
- 235000021313 oleic acid Nutrition 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 241000186660 Lactobacillus Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 235000020739 avocado extract Nutrition 0.000 description 6
- 235000010633 broth Nutrition 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 229940039696 lactobacillus Drugs 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
- 244000199866 Lactobacillus casei Species 0.000 description 5
- 235000013958 Lactobacillus casei Nutrition 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 235000004279 alanine Nutrition 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229940017800 lactobacillus casei Drugs 0.000 description 5
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 5
- BVIYGXUQVXBHQS-IUYQGCFVSA-N (2R,4S)-2-methyltetrahydrofuran-2,3,3,4-tetrol Chemical compound C[C@@]1(O)OC[C@H](O)C1(O)O BVIYGXUQVXBHQS-IUYQGCFVSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 210000003837 chick embryo Anatomy 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000007933 dermal patch Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012533 medium component Substances 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 108010038807 Oligopeptides Proteins 0.000 description 3
- 102000015636 Oligopeptides Human genes 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 3
- 230000018612 quorum sensing Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000005808 skin problem Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 208000006787 Port-Wine Stain Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 230000007269 microbial metabolism Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000004451 qualitative analysis Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008632 Cota tinctoria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108091023242 Internal transcribed spacer Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000166550 Strophanthus gratus Species 0.000 description 1
- 102000003566 TRPV1 Human genes 0.000 description 1
- 102100029613 Transient receptor potential cation channel subfamily V member 1 Human genes 0.000 description 1
- 101150016206 Trpv1 gene Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- BLHYIYKUEYNCSP-UHFFFAOYSA-M [Na+].CC([O-])=O.C1CCOC1.CCN(CC)CC Chemical compound [Na+].CC([O-])=O.C1CCOC1.CCN(CC)CC BLHYIYKUEYNCSP-UHFFFAOYSA-M 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- -1 dry skin Chemical compound 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002270 exclusion chromatography Methods 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000000897 modulatory effect Effects 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- AWBWZUHEUDDGKG-UHFFFAOYSA-M sodium acetonitrile methanol acetate Chemical compound [Na+].OC.CC#N.CC([O-])=O AWBWZUHEUDDGKG-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Definitions
- the invention relates to an avocado oil-in-water liquid fermentation product and a preparation method and application thereof, belonging to the field of fermentation and the technical field of skin care products.
- the skin is an important organ of the human body with a complex tissue structure and is closely connected with other organs of the human body, acting as a barrier to protect the human body from external stimuli and damage.
- the body functions of infants and young children have not yet fully developed, and the skin tissue is very different from that of adults. Due to the delicate skin and poor development of the stratum corneum, its protective function is weaker than that of adults, and it is easily damaged and microorganisms are easily invaded, so it is prone to eczema, allergies, and dryness. And so many skin problems.
- pregnant women are also prone to various skin problems under the influence of progesterone, such as dry skin, pigmentation, allergies, acne, etc., basic care is essential.
- Pregnant women have an increasing demand for safe and effective skin care products, and the development of mild, naturally fermented cosmetics has become an important direction to solve the skin problems of pregnant women.
- microbial metabolism produces extracellular enzymes such as pectinase and cellulase, which can promote the rupture of plant cells and release active ingredients. Microbial metabolism can also produce proteases, etc., which can effectively degrade macromolecular substances into small molecular substances, which are easier for the human body to absorb, thereby enhancing the efficacy of drugs.
- avocado also known as avocado, avocado, avocado, cream fruit, is a fruit with high nutritional value.
- avocado is rich in unsaturated fatty acids, vitamins, sterols, protein and some mineral elements, and has the reputation of "forest butter”. Eating avocado on a regular basis can help soften and moisturise the skin, as well as help shrink pores and make the skin look smoother and firmer.
- avocados are rich in vitamins and vegetable oils, which moisturize the skin and strengthen the skin's moisturizing properties; vitamins can soothe the skin, prevent aging, and to a certain extent prevent the early formation of wrinkles, delay the speed of skin aging, and prevent premature wrinkles.
- avocado is rich in nutrients, which can soothe and repair sensitive skin and strengthen the skin barrier. At present, there is no research report on the use of avocado fermented raw materials to prepare effective moisturizing and alleviating sensitive cosmetics.
- CN108815072A discloses a fermented puree of a plant composition and its preparation method and application. Although avocado is used, it actually removes the peel and pulp to get the avocado pit, and uses the avocado pit, golden chamomile and Honeysuckle flower petals, Aloe vera mesophyll, ginseng and Panax notoginseng roots are prepared as plant composition filtrate, and the compound bacterial liquid of Lactobacillus delbrueckii subsp.
- bulgaricus and natural Saccharomyces cerevisiae is used to ferment the plant composition filtrate to prepare the composition Fermented puree; the invention only uses the avocado pit as the raw material, and abandons the rich oil in the avocado pulp, and the fat (fruit oil) content in the avocado pulp accounts for about 20%, which is a natural moisturizing ingredient. Further, how to utilize the fat (fruit oil) in the avocado pulp is also a major problem at present.
- the traditional biological fermentation method is mostly carried out in the water phase. This traditional fermentation process is not compatible with avocado oil, and it is difficult for avocado oil to exist in it stably; other avocado fermentation processes are mostly aimed at the preservation of avocado pulp, and the fermented products It is semi-solid and cannot be used in the production of cosmetic raw materials.
- the oil-in-water liquid fermentation product of avocados of the present invention effectively converts proteins, nucleic acids, polysaccharides, etc.
- the small molecule water-soluble fermentation system uses the surfactant of probiotics to bio-refine the avocado oil and encapsulate it. That is, the fermentation process is used to convert the avocado into a stable mixed liquid fermentation product with polypeptides, amino acids, oligosaccharides, water-soluble microbial minerals, etc. as the water phase, and avocado oil wrapped with surfactants as the lipid phase. Nutrients are maximized.
- the avocado oil-in-water liquid fermented product obtained by the invention can be used for preparing cosmetics, has the effects of superior moisturizing performance, enhancing skin barrier, and food source, safety is more secure, and pregnant women and infants can use it with confidence.
- the first object of the present invention is to provide a preparation method of avocado oil-in-water liquid fermentation product, the method comprising: inoculating a microbial compound bacterial agent into a fermentation substrate with avocado as the main component, and fermenting and culturing to prepare ;
- Described microbial compound bacterial agent is the mixed bacterial agent that comprises the saccharomyces fascicularis and Lactobacillus pentosus.
- yeast enzymes are used to degrade polysaccharides and proteins, and the natural oils of avocados are retained; the surfactants produced by lactic acid bacteria are used to coat oil droplets.
- the Saccharomycopsis fibuligera is a high-yielding protease strain screened from liquor fermented grains, and has been deposited in the General Microbiology Center of the China Microorganism Culture Collection on December 21, 2020, and is preserved
- the serial number is CGMCC NO.21512, and the preservation address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- Lactobacillus pentosus (Lactobacillus pentosus) was obtained by screening from liquor fermented grains, and was deposited in the General Microbiology Center of the China Microorganism Culture Collection on December 21, 2020, and the preservation number is CGMCC NO.21511. The address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- the avocado includes avocado pulp and a fruit pit; optionally, the whole avocado fruit is obtained after cleaning, removing the stems and breaking the walls of fresh avocados.
- the inoculation of the compound bacterial agent is to inoculate a liquid bacterial agent, which is the addition of 5%-15% by volume of the complex microbial inoculum to the fermentation substrate.
- the inoculum of the composite microbial inoculum is 10%.
- the compound bacterial agent is a mixed bacterial agent of Saccharomyces spp. and Lactobacillus pentosus, wherein the volume ratio of Yeast saccharomyces pouches and Lactobacillus pentosus seed liquid is 1 :0.5-1:2.
- the volume ratio is 1:1.
- the fermentation is at 28-32°C for 25-30h.
- ferment at 30°C for 27h.
- the fermentation substrate is 80-120 g ⁇ L -1 of avocado and 15-25 g ⁇ L -1 of glucose.
- avocado 100g ⁇ L -1 and glucose 20g ⁇ L -1 .
- the fermentation culture is carried out in a ventilated environment.
- the preparation method comprises the following steps:
- the avocado is pulverized, sterilized, and mixed with glucose to obtain a mixed solution
- the second object of the present invention is to provide the avocado oil-in-water liquid fermentation product prepared according to the above method.
- the third object of the present invention is to provide a strain of Saccharomycopsis fibuligera suitable for whole fruit fermentation of avocado, which has been deposited in the General Microorganism Center of the China Committee for the Preservation of Microorganisms on December 21, 2020.
- the serial number is CGMCC NO.21512, and the preservation address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- the fourth object of the present invention is to provide a strain of Lactobacillus pentosus suitable for whole fruit fermentation of avocado, which has been deposited in the General Microorganism Center of the China Committee for the Preservation of Microorganisms on December 21, 2020, with a deposit number of It is CGMCC No. 21511, and the preservation address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- the fifth object of the present invention is to provide a composite inoculum suitable for whole fruit fermentation of avocado, the composite inoculum is the saccharomyces saccharomyces cerevisiae with the preservation number of CGMCC NO.21512 and the pentose with the preservation number of CGMCC NO.21511 Lactobacillus mixture.
- the sixth object of the present invention is to provide the preparation method of the above-mentioned avocado oil-in-water liquid fermentation product or the application of the avocado oil-in-water liquid fermentation product or the above-mentioned composite bacterial agent in the preparation of cosmetics.
- the cosmetic may be a toner, a serum, a lotion, a cream, or the like.
- an oil-in-water liquid fermented product of avocado is prepared, which has good resistance to lipid peroxidation, cell drying and damage repair capabilities, and has good beauty. skin, skin care effect.
- the seventh object of the present invention is to provide the preparation method of the above-mentioned avocado oil-in-water liquid fermentation product or the application of the avocado oil-in-water liquid fermentation product or the above-mentioned composite bacterial agent in the preparation of products with antioxidative and moisturizing effects.
- Saccharomycopsis fibuligera Z1-9 classified as Saccharomycopsis fibuligera, has been deposited in the General Microbiology Center of the China Commission for the Collection of Microorganisms on December 21, 2020, and the deposit number is CGMCC NO.21512.
- the address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- Lactobacillus pentosus C-7 classified as Lactobacillus pentosus, has been deposited in the General Microbiology Center of the China Microbiological Culture Collection Management Committee on December 21, 2020, the preservation number is CGMCC NO.21511, and the deposit address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- the fat content can reach 0.11 g ⁇ 100 -1 ⁇ g -1
- the protein content can reach 1813 ppm
- the amino acid content can reach 635 ppm
- the total phenolic content can reach 148 ppm
- the total sugar content can reach 1813 ppm.
- fatty acid composition is 8.50% palmitoleic acid, 20.78% palmitic acid, 9.81% linoleic acid, 52.06% oleic acid, 7.96% oleic acid, 0.89% stearic acid;
- peptide concentration is 9.68 ⁇ 0.22g ⁇ L -1 , rich in small molecule oligopeptides; rich in important components of natural moisturizing factor (NMF), among which, the concentration of alanine is 102.02ppm, the concentration of glutamic acid is 78.09ppm, and the concentration of aspartic acid is 78.09ppm.
- NMF natural moisturizing factor
- the acid concentration is 49.46ppm; the lipid peroxidation inhibition rate of 2.5% avocado oil-in-water liquid fermentation product is 23.29%, and the effect is close to 176ppm VC; the repair of dry damaged cells by 1.25% avocado oil-in-water liquid fermentation product is close to 10% glycerol 2.5% and 5.0% avocado oil-in-water liquid fermentation products can improve the cell repairing effect of dry damage by 27.35% and 29.83% respectively; green and safe, no hemolysis, no adverse reactions to the skin, no irritation.
- the oil-in-water liquid fermented product of the avocado of the present invention can be used as a cosmetic raw material for the preparation of cosmetics such as toner, essence, lotion or face cream, and has the functions of anti-oxidation and moisturizing.
- Figure 1 is a comparison of peptide concentrations
- Figure 2 is the comparison result of the sample fat morphology
- Figure 3 is the sample appearance comparison
- Fig. 4 is the graph after centrifugation of unfermented sample
- Fig. 5 is the GC-MS spectrum of the sample after fermentation
- Fig. 6 is the comparison result of the molecular weight distribution of sample peptide
- Fig. 7 is the amino acid concentration comparison before and after fermentation
- Fig. 8 is the anti-lipid peroxidation effect of avocado oil-in-water liquid fermentation product
- the avocados in the following examples are from commercially available, specifically California avocados.
- Saccharomycopsis fibuligera used in the embodiment was screened in liquor fermented fermented grains, and the preservation number was CGMCC NO.21512; Lactobacillus pentosus was screened in liquor fermented grains, and the preservation number was CGMCC NO.21511.
- YPD liquid culture medium is: 10.0 g of yeast powder, 20.0 g of peptone, 20.0 g of glucose, pH 6.5-6.7, supplemented with 1000 mL of deionized water.
- YPD solid medium is YPD liquid medium supplemented with 2% agar powder. After the medium components were prepared, they were sterilized at 121 °C for 20 min.
- MRS liquid medium is: peptone 10.0g, beef extract 10.0g, yeast powder 5.0g, diammonium hydrogen citrate 2.0g, glucose 20.0g, Tween 80 1.0g, sodium acetate trihydrate 5.0g g, K 2 HPO 4 ⁇ 3H 2 O 2.0g, MgSO 4 ⁇ 7H 2 O 0.58g, MnSO 4 ⁇ H 2 O 0.25g, pH 6.2 ⁇ 6.6, make up 1000mL of deionized water.
- MRS solid medium is MRS liquid medium supplemented with 2% agar powder. After the medium components were prepared, they were sterilized at 121 °C for 20 min.
- the formula of the solid medium for strain screening is: peptone 20.0g, yeast powder 1.0g, skim milk 10.0g, glucose 5.0g, KH 2 PO 4 1.0g, NaH 2 PO 4 2.4g, agar 20.0g, pH 6.8, make up Ionized water 1000mL. After the medium components were prepared, they were sterilized at 121 °C for 20 min.
- the strains showing a transparent circle were picked, and after isolation and purification, a single colony was picked and placed in YPD liquid medium, and cultured for 2 days under shaking conditions of 200r ⁇ min -1 and 30°C.
- the fermentation broth was centrifuged at 10,000 rpm for 10 min and the supernatant was taken to measure the protease activity.
- Determination of protease activity adopt GB/T 23527-2009 "Protease Preparation” method.
- Add 5 mL of Na 2 CO 3 and 1 mL of Folin-phenol reagent to 1 mL of the supernatant, mix evenly, and keep at 40 °C for 20 min, and measure the absorbance at a wavelength of 660 nm using a UV-Vis spectrophotometer.
- the group that first added trichloroacetic acid to terminate the reaction was used as the control group.
- the enzymatic activity is defined as follows: 1 mL of the test solution, in the environment of 40°C, can catalyze the production of casein by the required amount of enzyme equivalent to 1 ⁇ g of tyrosine per minute, that is, one enzymatic activity unit (U).
- strain Z1-9 The colonies of strain Z1-9 were round, white, fluffy, raised, with irregular edges. The morphological results were observed by microscope, and it was found that the isolated and screened strain cells were nearly elliptical, with different sizes, and some were budding and dividing.
- the strain Z1-9 was inoculated into YPD medium, cultured for 1 d, and the total DNA of the strain was extracted as a PCR template.
- Yeast ITS universal primers were used for PCR amplification, and the selected universal primers were ITS1 (nucleotide sequence: 5'-TCCGTAGGTGAACCTGCGG-3', sequence: SEQ ID NO: 1) and ITS4 (nucleotide sequence: 5'-TCCTCCGCTTATTGATATGC) -3', sequence as SEQ ID NO: 2).
- PCR amplification conditions 94°C for 5 min, 94°C for 30 s, 55°C for 30 s, 72°C for 1 min, cycle 30 times; 72°C for 10 min.
- PCR amplification products were sent to Suzhou Jinweizhi Biotechnology Co., Ltd. for sequencing after passing the 1% agarose gel inspection.
- the sequencing results were uploaded to the National Center for Biotechnology Information (NCBI) database for BLAST comparison, and the strain was found to be Saccharomycopsis fibuligera.
- NCBI National Center for Biotechnology Information
- the strain Z1-9 was preliminarily identified as Saccharomycopsis fibuligera by comprehensive colony morphological characteristics, physiological and biochemical characteristics and ITS sequence analysis.
- the strain was deposited in the General Microbiology Center of the China Microorganism Culture Collection Management Committee, with the preservation number of CGMCC NO.21512.
- Liquor fermentation is a mixed-bacteria fermentation process, in which abundant microorganisms adapt to each other and work synergistically during the long-term domestication process.
- the microorganisms screened in the same environment can better synergize. Therefore, the screening of surfactant-producing strains was performed from the growth environment of the yeast of Example 1.
- Different surfactants contain different components, and not all surfactants are suitable for the encapsulation of avocado oil. Therefore, the screening of surfactant-producing strains is carried out with the medium supplemented with avocado oil, and the process is as follows.
- avocado oil liquid medium avocado oil 8.0g, peptone 10.0g, beef extract 10.0g, yeast powder 5.0g, diammonium hydrogen citrate 2.0g, glucose 20.0g, K 2 HPO 4 3H 2 O 2.0g, MgSO 4 ⁇ 7H 2 O 0.58g, MnSO 4 ⁇ H 2 O 0.25g, pH 7.0, make up 1000 mL of deionized water. After the medium components were prepared, they were sterilized at 121 °C for 20 min.
- the single colonies obtained from the primary screening were respectively inoculated into the avocado oil liquid medium, shaken and cultured at 37°C, 200 r ⁇ min -1 shake flasks, and the strains with good avocado oil emulsifying effect were selected to obtain 4 strains.
- the four strains with avocado oil emulsifying effect were inoculated into MRS liquid medium, and cultured in shake flasks at 37°C, 200 r ⁇ min -1 for 2 d. After centrifugation, the diameter of the oil discharge circle of the supernatant was measured.
- Drain ring method the fermentation broth was centrifuged at 4000 rpm for 10 min, and the supernatant was taken for later use. Take a petri dish with a diameter of 9 cm, add 30 mL of distilled water, and drop 0.2 mL of avocado oil on the water surface. After an oil film is formed, add 0.2 mL of the fermentation broth supernatant diluted 2 times to the center of the oil film to form a stable oil drain. Measure the diameter of the oil drain ring.
- strain C-7 had the largest diameter of the oil discharge ring of the fermentation broth and produced the most biosurfactants.
- strain C-7 The colonies of strain C-7 were tiny round, white, raised, with neat edges. The morphological results were observed by microscope, and it was found that the isolated and screened strain cells were rod-shaped, short-chain-shaped, and had no spores.
- the strain C-7 was inoculated into MRS medium, cultured for 1 d, and the total DNA of the strain was extracted as a PCR template.
- PCR amplification was carried out using bacterial 16S universal primers, and the selected universal primers were 27F (the nucleotide sequence was 5'-AGAGTTTGATCMTGGCTCAG-3', the sequence was as SEQ ID NO: 3) and 1492R (the nucleotide sequence was 5'-TACGGHTACCTTGTTACGACTT) -3', sequence as SEQ ID NO: 4).
- PCR amplification conditions 94°C for 10 min, 94°C for 1 min, 55°C for 1 min, 72°C for 2 min, cycle 30 times; 72°C for 10 min.
- PCR amplification products were sent to Suzhou Jinweizhi Biotechnology Co., Ltd. for sequencing after passing the 1% agarose gel inspection.
- the sequencing results were uploaded to the National Center for Biotechnology Information (NCBI) database for BLAST comparison, and the strain was found to be Lactobacillus pentosus.
- NCBI National Center for Biotechnology Information
- the strain C-7 was preliminarily identified as Lactobacillus pentosus by comprehensive colony morphological characteristics, physiological and biochemical characteristics and 16S sequence analysis.
- the strain was deposited in the General Microbiology Center of the China Microorganism Culture Collection Management Committee, with the preservation number of CGMCC NO.21511.
- the composite microbial inoculum is from yeast Z1-9 and Lactobacillus pentosus C-7.
- the mixed inoculum is obtained by composing the saccharomyces cerevisiae seed liquid and the Lactobacillus pentosus seed liquid in a volume ratio of 1:1; when the fermentation process is carried out in a fermentation tank, the ventilation rate is 4sL ⁇ min -1 .
- Example 3 The only difference from Example 3 is that the composite microbial inoculum was not inoculated.
- Example 3 The only difference from Example 3 is that the yeast Z1-9 was fermented by single use.
- Example 3 The only difference from Example 3 is that Lactobacillus pentosus C-7 is used alone for fermentation.
- Example 3 The only difference from Example 3 is that the yeast CICC 33226 was used instead of the yeast of the present invention, and it was mixed with the Lactobacillus of the present invention for fermentation.
- CICC 33226 was purchased from China Industrial Microbial Culture Collection and Management Center, and it was found that it could produce protease by the transparent circle method.
- Example 3 The difference from Example 3 is that the yeast CICC 1717 is used instead of the yeast of the present invention, and is mixed with the Lactobacillus of the present invention for fermentation.
- CICC 1717 was purchased from China Industrial Microorganism Culture Collection and Management Center, and it was found that it could produce protease by transparent circle method.
- Example 3 Saccharomyces cerevisiae CICC 1210 is used instead of the yeast of the present invention, and is mixed with the Lactobacillus of the present invention for fermentation.
- Saccharomyces cerevisiae CICC 1210 was purchased from the China Industrial Microorganism Culture Collection and Management Center, and it was found that it could produce protease by the transparent circle method.
- Lactobacillus pentosus CICC 24202 is used instead of the Lactobacillus of the present invention, which is mixed with the yeast of the present invention for fermentation.
- Lactobacillus pentosus CICC 24202 was purchased from China Industrial Microorganism Culture Collection and Management Center.
- Lactobacillus casei CICC 20252 is used instead of the Lactobacillus of the present invention, which is mixed with the yeast of the present invention for fermentation.
- Lactobacillus casei CICC 20252 was purchased from China Industrial Microorganism Culture Collection and Management Center. It has been reported that Lactobacillus casei can produce biosurfactants (for details, see references: Ferreira A, Vecino X, Ferreira D, et al. Novel cosmetic formulations containing a biosurfactant from Lactobacillus paracasei. 2017, 155:522-529. ).
- Embodiment 4 Detection of avocado fermented products
- the oil-in-water liquid fermentation product of avocado prepared in Example 3 and Comparative Examples 1-8 were used as samples to be tested.
- the comparison results of the total polypeptide content of the samples are shown in Figure 1.
- the polypeptide concentration of Comparative Example 1 without microbial fermentation treatment was 874.03 ⁇ 18.46ppm.
- the highest content of polypeptide after fermentation is Example 3 of the present invention, and its concentration is 1330.64 ⁇ 36.90 ppm.
- the polypeptide concentration is increased by 52%.
- Comparative Example 3 The polypeptide concentration of Comparative Example 3 was similar to that of unfermented Comparative Example 1, indicating that Lactobacillus pentosus C-7 fermentation alone could not hydrolyze proteins in avocado into small molecular polypeptides.
- the polypeptide concentrations of Comparative Examples 4 to 6 are increased, but far less than the yeast used in Example 3. It is indicated that the yeast Z1-9 of the present invention is more suitable for the avocado fermentation system of the present invention in which the whole utilization of the avocado pulp and pits is carried out.
- the polypeptide content of Comparative Example 8 is lower than that of Example 3, the Lactobacillus casei CICC 20252 affects the effect of yeast Z1-9, and the Lactobacillus casei CICC 20252 cannot replace the Lactobacillus pentosus C-7 of the present invention .
- the avocado oil-in-water liquid fermentation product prepared in Example 3 of the present invention and Comparative Example 1, Comparative Example 2, and Comparative Example 7 were used as samples to be tested.
- Nile red can bind to lipids and emit a fluorescent detection signal.
- the samples were stained with Nile red, and the fat morphology was observed under a laser confocal microscope.
- the oil-in-water liquid fermented product of avocado prepared in Example 3 of the present invention was used as the sample to be tested.
- bovine serum albumin solutions of different concentrations to draw a standard curve.
- the active substance content of the oil-in-water liquid fermentation product of avocado is shown in Table 3.
- the avocado oil-in-water liquid fermented product obtained in Example 3 is rich in protein, amino acids, phenols and sugars, indicating that the fermentation method of the present invention can obtain the fermentation puree of high active ingredients.
- the avocado oil-in-water liquid fermentation product prepared in Example 3 of the present invention and the avocado extract prepared in Comparative Example 1 were used as samples to be tested.
- the fat content in the sample is calculated as follows:
- X The content of fat in the sample, the unit is g ⁇ 100 -1 ⁇ g -1 ;
- m 1 the content of the receiving bottle and fat after constant weight, the unit is g;
- the fat content in the fermented puree obtained in Example 3 after fermentation treatment of avocado was 0.11 g ⁇ 100 ⁇ 1 ⁇ g ⁇ 1
- the fat content in the extract obtained in Comparative Example 1 without fermentation treatment It is 0.15g ⁇ 100 -1 ⁇ g -1 , indicating that the avocado oil (fat) is still retained after fermentation.
- the avocado oil-in-water liquid fermentation product prepared in Example 3 of the present invention and the avocado extract prepared in Comparative Example 1 were centrifuged at 5000 ⁇ g for 10 min.
- the fatty acid composition of the above samples was analyzed by GC-MS.
- Chromatographic conditions Chromatographic column: HP-88 elastic quartz capillary column (100m ⁇ 0.25mm, 0.25 ⁇ m); the heating program is the initial temperature of 150°C for 2min, and the temperature is increased to 210°C at 2°C ⁇ min -1 , and the temperature is 50°C ⁇ min -1 was heated to 250°C for 10min.
- the temperature of the injection port was 250°C, the injection volume was 1 ⁇ L, the total flow rate was 35.6 mL ⁇ min -1 , the carrier gas was N 2 , and the split ratio was 50:1.
- Qualitative and quantitative analysis qualitative analysis was performed using NIST 14 and Wiley 9.0 mass spectrometry database, and the relative percentage of each component was calculated by area normalization method.
- the fatty acid composition of avocado oil-in-water liquid fermentation product and its relative percentage are shown in Table 5.
- the fat content of the oil-in-water liquid fermentation product of avocado was measured in the early stage to be 0.15 g ⁇ 100 -1 ⁇ g -1 .
- the concentration was estimated, as shown in Table 5.
- the most abundant oil-in-water liquid fermented product of avocado is oleic acid, accounting for 52.06% of the fatty acid composition, with a concentration of 572.66ppm.
- Oleic acid can inhibit the activity of the capsaicin receptor TRPV1, thereby reducing the pain and itching response to external stimuli (for details, see references: Morales-Lázaro Sara L, Llorente Itzel, Sierra-Ram ⁇ rez Félix, et al. Inhibition of TRPV1 channels by a naturally occurring omega-9 fatty acid reduces pain and itch. 2016, 7:13092.).
- oleic acid and essential fatty acids in avocados promote wound healing and help reduce inflammation during the healing process (for details see References: Sales-Campos Helioswilton, Souza Patric ⁇ a Reis de, Peghini Crema, et al. An overview of the modulatory effects of oleic acid in health and disease. 2013, 13(2):201-10.).
- stearic acid, palmitic acid, oleic acid, and linoleic acid in avocado all have inhibitory effects on the signaling molecule AI-2 (for details, see references: KWWidmer, KASoni, MEHume, et al.
- AI-2 is a signaling molecule for bacterial interspecies information exchange and a compound that plays a key role in bacterial cell quorum sensing. These fatty acids in avocado further inhibit the growth of pathogenic microorganisms by inhibiting quorum sensing.
- the avocado oil-in-water liquid fermentation product prepared in Example 3 of the present invention and the avocado extract prepared in Comparative Example 1 were used as samples to be tested.
- SEC-HPLC high-performance liquid space exclusion chromatography
- the avocado oil-in-water liquid fermentation product prepared in Example 3 of the present invention and the avocado extract prepared in Comparative Example 1 were used as samples to be tested.
- the content of free amino acids in the samples was detected using a high performance liquid chromatograph and a Diamonsil C18 (250mm ⁇ 4.6mm, 5 ⁇ m) chromatographic column. Pre-test samples were subjected to OPA-FMOC pre-column derivatization.
- Mobile phase A was 27.6 mmol ⁇ L -1 of sodium acetate-triethylamine-tetrahydrofuran (50:0.11:2.5, volume ratio), and the pH was adjusted to 7.2 by using acetic acid.
- Mobile phase B was 80.9 mmol ⁇ L -1 sodium acetate-methanol-acetonitrile mixture (1:2:2, volume ratio), and the pH was adjusted to 7.2 by using acetic acid.
- the UV detection wavelength was 338 nm, the flow rate was 1 mL ⁇ min -1 , the column temperature was 40 °C, and the injection volume was 10 ⁇ L.
- Alanine is a humectant and an important component of Natural Moisturizing Factor (NMF).
- NMF Natural Moisturizing Factor
- Embodiment 4 Application of avocado oil-in-water liquid fermentation product in cosmetics
- the avocado oil-in-water liquid fermented product prepared by the embodiment of the present invention 3 was used as the sample to be tested, and 176ppm VC was used as a negative control.
- lipid peroxidation inhibition rate was calculated according to the following formula.
- control group replaced the sample with its solvent, absorbance
- blank group 2 When the sample contains lipid, blank group 2 needs to be set additionally, that is, lecithin is not added on the basis of the sample group, and the absorbance
- Figure 8 shows the anti-lipid peroxidation efficacy of avocado oil-in-water liquid fermentation products.
- the lipid peroxidation inhibition rate of 2.5% avocado oil-in-water liquid fermentation product (the liquid fermentation product of Example 3 is diluted to 2.5% by volume with deionized water, the same below), 176ppm V C (ascorbic acid) is 23.29 ⁇ 2.67%. acid; vitamin C), the lipid peroxidation inhibition rate was 23.35 ⁇ 3.26%, indicating that the lipid peroxidation inhibition effect of 2.5% avocado oil-in-water liquid fermentation product was close to 176ppm V C .
- Reagents SDS (sodium dodecyl sulfate), DMEM medium, DMEM complete medium (added with 10% FBS fetal bovine serum and 1% double antibody), PBS buffer, glycerol (positive control), test samples, MTT, DMSO.
- the cultured cells were digested, centrifuged, counted with a hemocytometer, diluted at a concentration of 1.5 ⁇ 10 5 ⁇ mL -1 and added to a 96-well plate, and 100 ⁇ L of cell fluid was added to each well to reach 15,000 cells per well. Pay attention to pipetting during the plating process to reduce the influence of cell sedimentation. Place the 96-well plate in a 37°C, 5% CO2 incubator for 24-30h.
- the medium in the 96-well plate was discarded and washed 1-2 times with PBS. To each well was added 100 [mu]L of solid sample pre-dissolved in PBS. The low-concentration samples were diluted proportionally, and PBS was added first and then the high-concentration sample solution was added. The blank group and the injury group were added with 100 ⁇ L of PBS solution. Incubate in the incubator for 30 minutes.
- At least three parallel wells were set for each sample concentration, and six parallel wells were set for the blank group and the damaged group.
- Porcine red blood cells (2%, Beijing Bolsi Technology Co., Ltd.);
- PBS 0.27 g (2 mM) KH 2 PO 4 , 3.58 g (10 mM) Na 2 HPO 4 , 8 g NaCl and 0.2 g KCl were dissolved in 1 L of deionized water, and the pH was adjusted to 7.4 with hydrochloric acid.
- Negative control group PBS+porcine red blood cells
- Sample group avocado oil-in-water liquid fermentation product + pig red blood cells
- Hemolysis test The sample was dispersed in PBS or normal saline, the red blood cells and the sample were mixed evenly in a ratio of 2:3, incubated at 37°C for 10min, centrifuged at 10000r ⁇ min -1 for 3min, and the supernatant was taken to test the absorbance at 540nm.
- the oil-in-water liquid fermented product of avocado has no hemolysis at the maximum experimental concentration (90%, a certain amount of PBS needs to be added to the liquid to remove hemolysis caused by the difference in osmotic pressure inside and outside the cell), so HD 50 >90%.
- Volunteer requirements 30 normal subjects (20-40 years old), no clinical unhealed inflammatory skin disease, no scars, pigments, atrophy, port-wine stains or other blemishes in the skin to be tested. Investigators who have not participated in other clinical trials, those who have no highly sensitive constitution, and those who have not performed patch tests in the past month.
- Sample set 40% avocado oil-in-water liquid fermented product
- Volunteer requirements 30 normal subjects (20-40 years old), no clinical unhealed inflammatory skin disease, no scars, pigments, atrophy, port-wine stains or other blemishes in the skin to be tested. Investigators who have not participated in other clinical trials, those who have no highly sensitive constitution, and those who have not performed patch tests in the past month.
- Sample set 40% avocado oil-in-water liquid fermented product
- the sample dosage is about 0.020-0.025 mL
- the test site is the curved side of the hand forearm
- the test area is 3 ⁇ 3 cm 2 . Apply twice a day for 7 days.
- Chicken embryos SPF grade White Leghorn chicken, purchased from Beijing Merial Weitong Laboratory Animal Technology Co., Ltd.
- Culture conditions incubator temperature 37.5 ⁇ 0.5°C, relative humidity 55%-70%.
- PC1 1.0% SDS solution
- PC2 Positive control
- CAM preparation buy 0d-old chick embryos, 50-60g, turn them once a day during the incubation process, check the developmental status of the chick embryos when hatching to 5d-old, and peel off the egg shell at 6 days to expose the white egg membrane; use tweezers carefully The intima is removed, ensuring that the vascular membrane is not damaged.
- Formal test at least 6 chick embryos in each group, take 0.1 mL of the test substance as it is and directly drop it on the surface of CAM, observe the reaction of CAM, and record the time of each toxic effect within 5 minutes, accurate to seconds, including bleeding, Coagulation and vascular melting were three kinds of reactions, and the degree of reaction was recorded. The same procedure was used for positive and negative controls.
- sec H, sec L, and sec C represent the mean time (seconds) observed on the CAM membrane to begin bleeding, vascular fusion, and coagulation, respectively.
- the 100% avocado oil-in-water liquid fermented product in the sample group has no irritation, while the 1.0% SDS solution and 0.1mol/L NaOH solution in the control group have severe irritation, and the 0.9% NaCl solution has no irritation.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (10)
- 一种牛油果水包油液态发酵产品的制备方法,其特征在于,所述方法包括:将微生物复合菌剂接种至以牛油果为主要成分的发酵底物中进行发酵培养制成;所述微生物复合菌剂为包含扣囊复膜酵母和戊糖乳杆菌的混合菌剂。A preparation method of avocado oil-in-water liquid fermentation product, characterized in that, the method comprises: inoculating a microbial compound bacterial agent into a fermentation substrate with avocado as a main component, and fermenting and culturing to prepare; the microbial compound bacteria The agent is a mixed bacterial agent containing Saccharomyces fascicularis and Lactobacillus pentosus.
- 根据权利要求1所述的方法,其特征在于,所述扣囊复膜酵母(Saccharomycopsis fibuligera),已于2020年12月21日保藏于中国微生物菌种保藏管理委员会普通微生物中心,保藏编号为CGMCC NO.21512;所述戊糖乳杆菌(Lactobacillus pentosus),已于2020年12月21日保藏于中国微生物菌种保藏管理委员会普通微生物中心,保藏编号为CGMCC NO.21511。The method according to claim 1, wherein the Saccharomycopsis fibuligera has been deposited in the General Microbiology Center of the China Microorganism Culture Collection on December 21, 2020, and the deposit number is CGMCC NO.21512; The Lactobacillus pentosus has been deposited in the General Microbiology Center of the China Microorganism Culture Collection Administration Committee on December 21, 2020, and the deposit number is CGMCC NO.21511.
- 根据权利要求1所述的方法,其特征在于,所述牛油果包括牛油果果肉和果核;可选地,所述复合菌剂接种是接种液体菌剂,是发酵底物中加入体积比5%-15%的复合微生物菌剂。The method according to claim 1, wherein the avocado comprises avocado pulp and fruit stone; alternatively, the compound bacterial agent inoculation is an inoculation of a liquid bacterial agent, which is added to the fermentation substrate in a volume ratio of 5%- 15% compound microbial inoculum.
- 根据权利要求1-3任一所述的方法制备得到的牛油果水包油液态发酵产品。The avocado oil-in-water liquid fermentation product prepared according to the method described in any one of claims 1-3.
- 一株适用于牛油果全果发酵的扣囊复膜酵母(Saccharomycopsis fibuligera),已于2020年12月21日保藏于中国微生物菌种保藏管理委员会普通微生物中心,保藏编号为CGMCC NO.21512,保藏地址为北京市朝阳区北辰西路1号院3号。A strain of Saccharomycopsis fibuligera suitable for whole-fruit fermentation of avocado has been deposited in the General Microbiology Center of the China Microorganism Culture Collection on December 21, 2020, with the preservation number of CGMCC NO.21512 and the deposit address It is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- 一株适用于牛油果全果发酵的戊糖乳杆菌(Lactobacillus pentosus),已于2020年12月21日保藏于中国微生物菌种保藏管理委员会普通微生物中心,保藏编号为CGMCC NO.21511,保藏地址为北京市朝阳区北辰西路1号院3号。A strain of Lactobacillus pentosus suitable for whole fruit fermentation of avocado has been deposited in the General Microbiology Center of China Microorganism Culture Collection Management Committee on December 21, 2020, the preservation number is CGMCC NO.21511, and the deposit address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
- 适用于牛油果全果发酵的复合菌剂,所述复合菌剂为保藏编号为CGMCC NO.21512的扣囊复膜酵母和保藏编号为CGMCC NO.21511的戊糖乳杆菌的混合菌剂。The compound inoculum suitable for whole avocado fermentation, the compound inoculum is the mixed inoculum of the yeast with the preservation number of CGMCC NO.21512 and the Lactobacillus pentosus with the preservation number of CGMCC NO.21511.
- 权利要求1-3任一所述的牛油果水包油液态发酵产品的制备方法或者权利要求4所述的牛油果水包油液态发酵产品或者权利要求7所述的复合菌剂在制备化妆品方面的应用。Application of the preparation method of the oil-in-water liquid fermented product of any one of claims 1-3 or the oil-in-water liquid fermented product of claim 4 or the composite bacterial agent of claim 7 in the preparation of cosmetics .
- 根据权利要求8所述的应用,其特征在于,所述化妆品是爽肤水、精华液、乳液或面霜中的任意一种。The application according to claim 8, wherein the cosmetic is any one of toner, essence, lotion or face cream.
- 权利要求1-3任一所述的牛油果水包油液态发酵产品的制备方法或者权利要求4所述的牛油果水包油液态发酵产品或者权利要求7所述的复合菌剂在制备具有抗氧化、保湿的作用的产品方面的应用。The preparation method of the oil-in-water liquid fermented product of any one of claims 1-3 or the oil-in-water liquid fermented product of claim 4 or the composite bacterial agent of claim 7 has antioxidant, Moisturizing effect of the product in terms of application.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110029047.0 | 2021-01-11 | ||
CN202110029047.0A CN112708652B (en) | 2021-01-11 | 2021-01-11 | Avocado oil-in-water liquid state fermentation product and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022147873A1 true WO2022147873A1 (en) | 2022-07-14 |
Family
ID=75548689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/075386 WO2022147873A1 (en) | 2021-01-11 | 2021-02-05 | Avocado oil-in-water liquid fermented product, and preparation method therefor and use thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112708652B (en) |
WO (1) | WO2022147873A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003020231A2 (en) * | 2001-08-31 | 2003-03-13 | The Procter & Gamble Company | Deodorant composition |
CN108251317A (en) * | 2018-03-30 | 2018-07-06 | 陕西枫丹百丽生物科技有限公司 | One plant of saccharomycopsis fibuligera and its application |
CN111088174A (en) * | 2019-12-30 | 2020-05-01 | 上海应用技术大学 | Saccharomycetes Fungiensis with oxidation resistance and whitening effect and application thereof |
CN111363697A (en) * | 2020-03-16 | 2020-07-03 | 沈阳师范大学 | Lactobacillus pentosus, application and preparation method of fermented bread |
CN111514077A (en) * | 2020-04-02 | 2020-08-11 | 珠海中科先进技术研究院有限公司 | Lactobacillus pentosus aloe fermented raw juice, preparation method, preservation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107927786A (en) * | 2017-12-28 | 2018-04-20 | 广西南宁桂尔创环保科技有限公司 | A kind of method that polyphenol is extracted from butter fruit |
CN107981142A (en) * | 2017-12-28 | 2018-05-04 | 广西南宁桂尔创环保科技有限公司 | A kind of preparation method of butter fruit vinegar beverage |
WO2020098097A1 (en) * | 2018-11-12 | 2020-05-22 | 中粮营养健康研究院有限公司 | Fermented lactobacillus plantarum and application thereof |
-
2021
- 2021-01-11 CN CN202110029047.0A patent/CN112708652B/en active Active
- 2021-02-05 WO PCT/CN2021/075386 patent/WO2022147873A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003020231A2 (en) * | 2001-08-31 | 2003-03-13 | The Procter & Gamble Company | Deodorant composition |
CN108251317A (en) * | 2018-03-30 | 2018-07-06 | 陕西枫丹百丽生物科技有限公司 | One plant of saccharomycopsis fibuligera and its application |
CN111088174A (en) * | 2019-12-30 | 2020-05-01 | 上海应用技术大学 | Saccharomycetes Fungiensis with oxidation resistance and whitening effect and application thereof |
CN111363697A (en) * | 2020-03-16 | 2020-07-03 | 沈阳师范大学 | Lactobacillus pentosus, application and preparation method of fermented bread |
CN111514077A (en) * | 2020-04-02 | 2020-08-11 | 珠海中科先进技术研究院有限公司 | Lactobacillus pentosus aloe fermented raw juice, preparation method, preservation method and application thereof |
Non-Patent Citations (3)
Title |
---|
CHI, Z. ; CHI, Z. ; LIU, G. ; WANG, F. ; JU, L. ; ZHANG, T.: "Saccharomycopsis fibuligera and its applications in biotechnology", BIOTECHNOLOGY ADVANCES., ELSEVIER PUBLISHING, BARKING., GB, vol. 27, no. 4, 1 July 2009 (2009-07-01), GB , pages 423 - 431, XP026127892, ISSN: 0734-9750, DOI: 10.1016/j.biotechadv.2009.03.003 * |
TIAN SUMEI, ET AL.: "Research Progress on Processing Techniques of Avocado ", ANHUI NONGYE - MODERN AGRICULTURAL SCIENCE AND TECHNOLOGY, ANHUI SHENG NONGYETING, CN, no. 7, 31 December 2018 (2018-12-31), CN , pages 251 - 252, XP055949179, ISSN: 1007-5739 * |
WANG LIYUAN, ET AL.: "Optimization on aqueous enzymatic extraction of avocado oil by response surface method", FOOD SCIENCE AND TECHNOLOGY, BEIJING SHI LIANGSHI KEXUE YANJIUSUO,, CN, vol. 43, no. 4, 31 December 2018 (2018-12-31), CN , pages 235 - 241, XP055949181, ISSN: 1005-9989, DOI: 10.13684/j.cnki.spkj.2018.04.043 * |
Also Published As
Publication number | Publication date |
---|---|
CN112708652B (en) | 2022-10-21 |
CN112708652A (en) | 2021-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2474237B1 (en) | Equol-containing fermentation product of soybean embryonic axis, and method for production thereof | |
US10251824B2 (en) | Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method | |
CN108096146A (en) | With whitening and anti-aging, the rose enzyme of anti-inflammatory effect and its application in cosmetics | |
CN113520942B (en) | Anti-oxidation and anti-aging five-ginseng fermentation product and preparation method and application thereof | |
CN114209617B (en) | Ganoderma lucidum extract fermented by yeast and preparation method and application thereof | |
KR100803998B1 (en) | Fermented extract of Citrus Sunkii Hort, Method for processing thereof, and the healthy and funtional foods | |
TWI802194B (en) | Use of noni fruit ferment in the manufacture of product for improving body shape and improving skin condition | |
KR20190006126A (en) | High yield ginsenoside biosynthesis inducing composition obtained from cultured ginseng callus cell of Korean and their uses | |
KR100873372B1 (en) | Boehmeria pannosa extract and anticancer containing thereof | |
WO2022147873A1 (en) | Avocado oil-in-water liquid fermented product, and preparation method therefor and use thereof | |
CN116355816A (en) | Microorganism of fermented samara oil seed and blood lipid reducing composition thereof | |
CN115317432B (en) | Mask containing bifidobacterium lactis fermentation product | |
KR102173406B1 (en) | Composition for Improving Skin Conditions with Exfoliation, Moisturizing, and Skin Soothing Property Comprising Complex Extract of Mangifera indica as Active Ingredient | |
CN113855765A (en) | Glutinous rice fermented extract and anti-aging application thereof | |
KR20130008823A (en) | An improving method for antioxidant activity of extracts derived from natural herbal material and their application to cosmetic composition for the prevention of aging or medical composition for antioxidation and anti-inflammation | |
KR101985660B1 (en) | Cosmetic composition for treating acne containing mixed herbal extracts fermented with Nuruk | |
TWI801770B (en) | Uses of nostoc sphaeroides extract for reducing body fat and enhancing skin appearance | |
CN110354050A (en) | A kind of anti-aging composition, preparation method and applications | |
TW202017585A (en) | Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells | |
CN114949039B (en) | Plant ferment and use thereof for producing lipid-reducing compositions | |
CN116270262B (en) | Liposome solution, external preparation containing liposome solution for skin, and preparation method and application of external preparation | |
CN115869203B (en) | Glycyrrhizin composite fermentation liquor, product containing same, preparation and application thereof | |
CN114903839B (en) | Facial essence containing bifidobacterium lactis fermentation product | |
CN117717507B (en) | Hair-blacking and hair-loss-preventing essence containing plant extracts and preparation method thereof | |
US20220175654A1 (en) | Phytocomplex and extract of a meristematic cell line selected from a plant belonging to the genus rosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21916925 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21916925 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21916925 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC |